165 related articles for article (PubMed ID: 33378985)
1. Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers.
Ghafouri-Fard S; Dashti S; Farsi M; Taheri M
Biomed Pharmacother; 2021 Jan; 133():111093. PubMed ID: 33378985
[TBL] [Abstract][Full Text] [Related]
2. Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer.
Qu X; Cao YX; Xing YX; Liu Q; Li HJ; Yang WH; Wang BQ; Han SY; Wang YS
Clin Transl Oncol; 2023 Oct; 25(10):2772-2782. PubMed ID: 37095423
[TBL] [Abstract][Full Text] [Related]
3. DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis.
Xu W; Wang B; Cai Y; Guo C; Liu K; Yuan C
Curr Pharm Des; 2021; 27(20):2337-2343. PubMed ID: 33106136
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
6. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
He T; Yuan C; Zhao C
Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
[TBL] [Abstract][Full Text] [Related]
7. Role of lncRNA LUCAT1 in cancer.
Xing C; Sun SG; Yue ZQ; Bai F
Biomed Pharmacother; 2021 Feb; 134():111158. PubMed ID: 33360049
[TBL] [Abstract][Full Text] [Related]
8. UCA1 lncRNA in metastases and prognosis.
Song W; Wang K; Zou SB
Panminerva Med; 2017 Sep; 59(3):278-279. PubMed ID: 28665101
[No Abstract] [Full Text] [Related]
9. BCYRN1: An oncogenic lncRNA in diverse cancers.
Ghafouri-Fard S; Dashti S; Hussen BM; Farsi M; Taheri M
Pathol Res Pract; 2021 Apr; 220():153385. PubMed ID: 33647864
[TBL] [Abstract][Full Text] [Related]
10. The dual functions of the long noncoding RNA CASC15 in malignancy.
Gu X; Chu Q; Zheng Q; Wang J; Zhu H
Biomed Pharmacother; 2021 Mar; 135():111212. PubMed ID: 33433353
[TBL] [Abstract][Full Text] [Related]
11. The role and mechanism of HLA complex group 11 in cancer.
Yuan X; Zhao Q; Zhang Y; Xue M
Biomed Pharmacother; 2021 Nov; 143():112210. PubMed ID: 34563948
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.
Garding A; Bhattacharya N; Claus R; Ruppel M; Tschuch C; Filarsky K; Idler I; Zucknick M; Caudron-Herger M; Oakes C; Fleig V; Keklikoglou I; Allegra D; Serra L; Thakurela S; Tiwari V; Weichenhan D; Benner A; Radlwimmer B; Zentgraf H; Wiemann S; Rippe K; Plass C; Döhner H; Lichter P; Stilgenbauer S; Mertens D
PLoS Genet; 2013 Apr; 9(4):e1003373. PubMed ID: 23593011
[TBL] [Abstract][Full Text] [Related]
14. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Ma W; Zhang CQ; Dang CX; Cai HY; Li HL; Miao GY; Wang JK; Zhang LJ
Biomed Pharmacother; 2019 May; 113():108655. PubMed ID: 30849637
[TBL] [Abstract][Full Text] [Related]
17. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
19. PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target.
Ghafouri-Fard S; Dashti S; Taheri M
Exp Mol Pathol; 2020 Jun; 114():104429. PubMed ID: 32220602
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types.
Botti G; Collina F; Scognamiglio G; Aquino G; Cerrone M; Liguori G; Gigantino V; Malzone MG; Cantile M
Curr Drug Targets; 2018; 19(10):1220-1226. PubMed ID: 28641521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]